NCT02732769

Brief Summary

the Mask fixation isn't a new solution for the immobilization of the patient's head and has been used in current practice for long years. This trial is attempting to compare these two technical possibilities of head fixation by mask or by stereotaxic frame. The primary goal is to evaluate the comfort for the patient and specifically for each step of the procedure. It will also evaluate other parameters such as the effectiveness of these two strategies and tolerance.The expected benefit is an improvement of the comfort for the patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable lung-cancer

Timeline
Completed

Started Feb 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 30, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 11, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 27, 2017

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 21, 2018

Completed
Last Updated

October 3, 2018

Status Verified

April 1, 2016

Enrollment Period

1.5 years

First QC Date

March 30, 2016

Last Update Submit

October 1, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluation of pain during the hospitalization (3 days)

    Questionary (numeric pain intensity scale)

    12 months

Secondary Outcomes (3)

  • Evaluation of tumor control at 3 months

    12 months

  • Evaluation of tumor control at 6 months

    12 months

  • Occurrence of clinical side effects

    12 months

Study Arms (2)

Group treated by radiosurgery with stereotaxic frame

ACTIVE COMPARATOR

Subjects will receive a radiosurgery during a brief hospitalization by LeksellGammaKnifePerfexion® (LGKP)

Device: GammaKnifePerfexion®Device: MRI

Group treated by radiosurgery with the thermoformed mask

EXPERIMENTAL

Subjects will receive a radiosurgery with thermoformed mask during a brief hospitalization by GammaKnifeICON® (GKI) with Efficast®

Device: GammaKnifeIcon®Device: Efficast®Device: MRI

Interventions

neurosurgery

Group treated by radiosurgery with stereotaxic frame

neurosurgery

Group treated by radiosurgery with the thermoformed mask

Thermoformed mask

Group treated by radiosurgery with the thermoformed mask
MRIDEVICE
Group treated by radiosurgery with stereotaxic frameGroup treated by radiosurgery with the thermoformed mask

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject bearing of one to five intellectual metastases of lung origin at the time of the indication of the radiosurgery
  • Subject requiring a radiosurgical treatment with LGK

You may not qualify if:

  • Subject having hurts of the brainstem or para-optics
  • Pregnant women or in feeding period
  • Subject having received previously a whole brain radiotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assistance Publique Hôpitaux de Marseille

Marseille, 13354, France

Location

MeSH Terms

Conditions

Lung NeoplasmsBrain Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesCentral Nervous System NeoplasmsNervous System NeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • DESALBRES

    ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 30, 2016

First Posted

April 11, 2016

Study Start

February 1, 2016

Primary Completion

July 27, 2017

Study Completion

March 21, 2018

Last Updated

October 3, 2018

Record last verified: 2016-04

Data Sharing

IPD Sharing
Will not share

Locations